Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Paciotti

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
Minerva Urology and Nephrology|September 20, 2023
Retroperitoneal approach for robot-assisted partial nephrectomy: still underused despite the supporting evidenceMarco Paciotti, Federico Piramide, Carlo A Bravi, et al.
Urologic Oncology|March 19, 2021
Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinomaMarco Paciotti, David-Dan Nguyen, Daniele Modonutti, et al.
Plos One|November 29, 2016
Low Birth Weight Is Associated with a Decreased Overall Adult Health Status and Reproductive Capability - Results of a Cross-Sectional Study in Primary Infertile PatientsLuca Boeri, Eugenio Ventimiglia, Paolo Capogrosso, et al.
BJU International|November 7, 2022
European training in urology (ENTRY): quality-assured training for European urology residentsNicolò Buffi, Marco Paciotti, Anthony G Gallagher, et al.
European Urology Oncology|June 1, 2021
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) ExperienceRoberto Contieri, Marco Paciotti, Giovanni Lughezzani, et al.
Minerva Urology and Nephrology|August 2, 2021
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic?Marco Paciotti, Roberto Contieri, Vittorio Fasulo, et al.
Urologic Oncology|June 29, 2021
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysisPier Paolo Avolio, Giovanni Lughezzani, Marco Paciotti, et al.
European Urology Focus|October 18, 2020
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective StudyGiovanni Lughezzani, Davide Maffei, Alberto Saita, et al.
The Journal of Urology|March 11, 2021
Reply by AuthorsDavid-Dan Nguyen, Lorine Haeuser, Marco Paciotti, et al.
Urologic Oncology|November 26, 2019
Risk factors and reasons for reoperation after radical cystectomyStephen W Reese, Emily Ji, Marco Paciotti, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
Minerva Urology and Nephrology|September 20, 2023
Retroperitoneal approach for robot-assisted partial nephrectomy: still underused despite the supporting evidenceMarco Paciotti, Federico Piramide, Carlo A Bravi, et al.
Urologic Oncology|March 19, 2021
Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinomaMarco Paciotti, David-Dan Nguyen, Daniele Modonutti, et al.
Plos One|November 29, 2016
Low Birth Weight Is Associated with a Decreased Overall Adult Health Status and Reproductive Capability - Results of a Cross-Sectional Study in Primary Infertile PatientsLuca Boeri, Eugenio Ventimiglia, Paolo Capogrosso, et al.
BJU International|November 7, 2022
European training in urology (ENTRY): quality-assured training for European urology residentsNicolò Buffi, Marco Paciotti, Anthony G Gallagher, et al.
European Urology Oncology|June 1, 2021
Long-term Follow-up and Factors Associated with Active Surveillance Failure for Patients with Non-muscle-invasive Bladder Cancer: The Bladder Cancer Italian Active Surveillance (BIAS) ExperienceRoberto Contieri, Marco Paciotti, Giovanni Lughezzani, et al.
Minerva Urology and Nephrology|August 2, 2021
Active surveillance for recurrent non-muscle invasive bladder cancer: which lessons have we learned during COVID-19 pandemic?Marco Paciotti, Roberto Contieri, Vittorio Fasulo, et al.
Urologic Oncology|June 29, 2021
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysisPier Paolo Avolio, Giovanni Lughezzani, Marco Paciotti, et al.
European Urology Focus|October 18, 2020
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective StudyGiovanni Lughezzani, Davide Maffei, Alberto Saita, et al.
The Journal of Urology|March 11, 2021
Reply by AuthorsDavid-Dan Nguyen, Lorine Haeuser, Marco Paciotti, et al.
Urologic Oncology|November 26, 2019
Risk factors and reasons for reoperation after radical cystectomyStephen W Reese, Emily Ji, Marco Paciotti, et al.
Pageof 14